Anne Fourie, Ph.D., has held several positions of increasing responsibility during her more than 20-year career at the Janssen Pharmaceutical Companies of Johnson & Johnson. In her current role, Anne is responsible for driving the strategic direction of the Psoriasis Disease Area Stronghold, maximizing and progressing the current portfolio, and executing new approaches for disease interception. She also offers extensive oral drug discovery expertise in immunology, as well as diverse experience in leading projects from target discovery through early development.